Market Size and Growth
As per the Urology Devices Market size analysis conducted by the BRI team, the urology devices market is expected to record a CAGR of 7.23% from 2025 to 2034. In 2025, the market size was USD 6.94 Billion. By 2034, the valuation is anticipated to reach USD 12.96 Billion.
Overview
As per the industry experts at BRI, the global urology devices market will witness a sustainable CAGR between 2025 and 2034. This could be attributed to an increase in urological disorders (cancers, kidney stones, incontinence), aging population, and technological advancements such as minimally invasive tools (MIS) and robotics. The key factors include robust demand for diagnostics & treatments, strategic R&D activities by the major players such as Boston Scientific and Medtronic, increased adoption of telehealth/AI, and a shift to Ambulatory Service Centers (ASCs)/outpatient settings. The Asia-Pacific region is expected to witness the highest rate of growth during the forecast period.
Key Trends & Drivers
- Prevalence of Urological Disorders followed by MIS to Spell Growth: Rising incidences of kidney stones, incontinence, and urological cancers are the primary drivers. Furthermore, an increased geriatric population results in a higher prevalence of urological issues related to age. Also, rising demand for robotics-assisted surgery (such as the MONARCH system), laser therapies, endourology, and digital diagnostics. Minimally invasive procedures are also strongly preferred, which reduces recovery time.
- New Product Launches and Inorganic Modes to Determine Growth: Instruments such as lithotripters and endoscopes dominate the urology devices market. The demand for consumables such as stents and catheters is also rising. Robotic systems are also poised to hold a sizable market share. New product launches (such as the UroLift System in India), mergers & acquisitions, and increased R&D activities are driving the market.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 6.94 Billion |
| Projected Market Size in 2034 | USD 12.96 Billion |
| Market Size in 2024 | USD 6.47 Billion |
| CAGR Growth Rate | 7.23% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Production Type, Application, End-user and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
SWOT Analysis
- Strengths: Technological innovations in the form of advanced lasers, robotics, and endoscopy for less invasive, accurate treatments (for instance – removal of kidney stones and prostate surgery) are the strengths of the urology devices market. Also, there is a broad spectrum of complex robotic systems, imaging, and consumables available. The market players such as Siemens, Intuitive Surgical, and Abbott (apart from Medtronic, Boston Scientific, and Olympus) are also engaging in organic and inorganic modes of expansion.
- Weaknesses: MRI scanners and robotic systems are expensive, thereby limiting their access in the low-income regions. Also, the market is heavily dependent on procurement from hospitals, thereby affecting wider reach.
- Opportunities: Increased incidences of benign prostate hyperplasia (BPH), chronic kidney disease (CKD), and cancers are bound to provide growth opportunities for urology devices market. Also, there is an untapped potential in Latin America and Asia Pacific, which are spending heavily on healthcare. Growing demand for disposable cystoscopies also ought to provide growth opportunities.
- Threats: Approvals from the FDA/CE do add to cost as well as delay. The payer policies are also affecting the affordability for patients and the adoption of devices. Global economic downturns are also expected to adversely affect capital expenditure of the hospitals.
List of the prominent players in the Urology Devices Market:
- Fresenius Medical Care AG & Co. KGaA
- Boston Scientific Corporation
- Becton Dickinson and Company
- Braun Melsungen AG
- Cardinal Health
- Olympus Corporation
- Intuitive Surgical
- Coloplast A/S
- Stryker Corporation
- Teleflex Incorporated
- Convatec Group PLC
- Medtronic PLC
- Others
The Urology Devices Market is segmented as follows:
By Production Type
- Endoscopes
- Cystoscopes
- Disposable
- Reusable
- Ureteroscopes
- Disposable
- Reusable
- Other Endoscopes
- Cystoscopes
- Laser & Lithotripsy Devices
- Dialysis Devices
- Accessories
By Application
- Urolithiasis
- Urethral Malignancies
- Bladder Disorders
- Kidney Diseases
By End-user
- Hospitals & Ambulatory Surgical Centers
- Dialysis Centers
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
[embedsocial_reviews id=”d4ae80cffae3d938f997111953699a733c8e6f99″]